Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00026858
Status:
COMPLETED
Last Update Posted:
2008-03-04
First Post:
2001-11-14
Brief Title:
Total Body Irradiation for Bone Marrow Transplants Collaborative Efforts
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Total Body Irradiation for Bone Marrow Transplants Collaborative Efforts
Status:
COMPLETED
Status Verified Date:
2002-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Most bone marrow transplantations for malignant and non-malignant disease include whole body irradiation Techniques for administering that treatment including patient positioning lung and soft tissue compensation dose rate total dose and fractionation differ between institutions These differences are optimized at each institution to limit toxicity and maximize therapeutic outcome
Technically complex procedures such as total body radiation are subject to equipment failures Such failures mid-treatment could be catastrophic to the patient since therapy must be timely and compatible therapy may not be available elsewhere in the community The purpose of this protocol is to provide backup between George Washington University Medical Center and the Radiation Oncology Branch of the NCI to allow for orderly safe and compatible therapies in the event of equipment failure or replacement of a linear accelerator or any other malfunctioning equipment necessary to deliver TBI or any emergent situation
Technically complex procedures such as total body radiation are subject to equipment failures Such failures mid-treatment could be catastrophic to the patient since therapy must be timely and compatible therapy may not be available elsewhere in the community The purpose of this protocol is to provide backup between George Washington University Medical Center and the Radiation Oncology Branch of the NCI to allow for orderly safe and compatible therapies in the event of equipment failure or replacement of a linear accelerator or any other malfunctioning equipment necessary to deliver TBI or any emergent situation
Detailed Description:
Most bone marrow transplantations for malignant and non-malignant disease include whole body irradiation Techniques for administering that treatment including patient positioning lung and soft tissue compensation dose rate total dose and fractionation differ between institutions These differences are optimized at each institution to limit toxicity and maximize therapeutic outcome
Technically complex procedures such as total body radiation are subject to equipment failures Such failures mid-treatment could be catastrophic to the patient since therapy must be timely and compatible therapy may not be available elsewhere in the community The purpose of this protocol is to provide backup between George Washington University Medical Center and the Radiation Oncology Branch of the NCI to allow for orderly safe and compatible therapies in the event of equipment failure or replacement of a linear accelerator or any other malfunctioning equipment necessary to deliver TBI or any emergent situation
Technically complex procedures such as total body radiation are subject to equipment failures Such failures mid-treatment could be catastrophic to the patient since therapy must be timely and compatible therapy may not be available elsewhere in the community The purpose of this protocol is to provide backup between George Washington University Medical Center and the Radiation Oncology Branch of the NCI to allow for orderly safe and compatible therapies in the event of equipment failure or replacement of a linear accelerator or any other malfunctioning equipment necessary to deliver TBI or any emergent situation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 95-C-0003 | None | None | None |